List of medicines to avoid in Primary Care Health and their application in polymedicated patients

被引:0
|
作者
Montans-Garcia, Raquel [1 ]
Gomez-Besteiro, Maria I. [2 ]
Campos-Toimil, Manuel [3 ]
Balboa-Barreiro, Vanesa [2 ]
机构
[1] Area Sanitaria A Coruna & Cee, Serv Atenc Primaria Cee, Sergas, Spain
[2] Univ A Coruna, Unidad Apoio Invest, Complexo Hop Univ Coruna, Area Sanitaria Coruna & Cee,Inst Invest Biomed Co, Sergas, Spain
[3] Univ Santiago de Compostela, Dept Farmacol FICAEC, Ctr Invest Med Mol & Enfermedades Cron CIMUS, Santiago De Compostela, Spain
来源
GALICIA CLINICA | 2022年 / 83卷 / 01期
关键词
Polypharmacy; Primary Health Care; Drug Utilization Review; POTENTIALLY INAPPROPRIATE MEDICATIONS; CRITERIA;
D O I
10.22546/64/2499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The high prevalence of inappropriate medication use and its important health consequences for health require specific and agile tools to detect and avoid it. The objective of this work was to elaborate a list of medications to avoid in Primary Care and to apply it on the polymedicated patients of a Primary Care assistance service. Methods: In the Database of the Spanish General Council of Official Associations of Pharmacists (BOT-Plus) the status and availability of each of the 93 MAE of the Prescrire 2019 List was checked. The list of medications to be avoided in Primary Care was drawn up with those that were marketed in Spain and excluded those that were not financed and those for exclusive hospital use. With the list of medicines to avoid in Primary Care, a retrospective analysis was made of all the prescription reports of polimedicated >10 medications for 2017 in a Primary Care services (N=262) in 5 health centers. Frequency analysis, central tendency measures and dispersion were carried out; they were estimated [CI: 95%] and X or Fisher's exact was used to determine the association between variables and logistic regression analysis. Results: A prevalence of polymedicated drugs of 1.2% was observed, with a mean age of 71.7 years (DT +/- 12.4) and a mean prescription of 12 drugs (DT +/- 1.7). The list of medications to be avoided in PC included 45 active ingredients. The 50.4% of the polymedicated had at least one drug to avoid and an average age of 68.5 years (DT +/- 11.8). Sex was a risk factor for inappropriate prescription, the fact of being a woman increases with an OR=1.8 (IC95%=1, 3-3.0) the probability of having some medicines to avoid. The most commonly used drugs to avoid were: duloxetine, sitagliptin and olmesartan. Conclusions: A high percentage of polymedicated patients are prescribed at least one drug to avoid. The Primary Care medication avoidance list is a useful tool for identifying inappropriate medication and for the use by Primary Care professionals.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [2] Access to medicines by patients of the primary health care in the Brazilian Unified Health System
    Alvares, Juliana
    Guerra Junior, Augusto Afonso
    de Araujo, Vania Eloisa
    Almeida, Alessandra Maciel
    Dias, Carolina Zampirolli
    Ascef, Bruna de Oliveira
    Costa, Edina Alves
    Guibu, Ione Aquemi
    Soeiro, Orlando Mario
    Leite, Silvana Nair
    de Oliveira Karnikowski, Margo Gomes
    Costa, Karen Sarmento
    Acurcio, Francisco de Assis
    REVISTA DE SAUDE PUBLICA, 2017, 51 : 1s - 9s
  • [3] Use of medicines by patients of the primary health care of the Brazilian Unified Health System
    Franco Neves Costa, Clarisse Melo
    Silveira, Micheline Rosa
    Acurcio, Francisco de Assis
    Guerra Junior, Augusto Afonso
    Guibu, Ione Aquemi
    Costa, Karen Sarmento
    de Oliveira Karnikowski, Margo Gomes
    Soeiro, Orlando Mario
    Leite, Silvana Nair
    Costa, Edina Alves
    Rezende Macedo do Nascimento, Renata Cristina
    de Arauo, Vania Eloisa
    Alvares, Juliana
    REVISTA DE SAUDE PUBLICA, 2017, 51 : 1s - 11s
  • [4] Effectiveness of a pharmacist provided intervention in reducing potentially inappropriate prescriptions in polymedicated patients in primary health care
    Medina-Catalan, David
    Lopez-Faixo, David
    Modamio, Pilar
    Garcia-Sanchez, Vanesa
    Moreno-Gil, Queralt
    Marino, Eduardo L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 311 - 311
  • [5] Medication review of the polymedicated patient in primary care
    Flores Dorado, Macarena
    Baena Parejo, Isabel
    Jimenez Martin, Jose
    Faus Dader, Maria Jose
    ATENCION PRIMARIA, 2013, 45 (04): : 222 - 223
  • [6] Feasibility study of a clinical decision support system for polymedicated patients in primary care
    Manzanet, Juan Manuel Pinar
    Fico, Giuseppe
    Merino-Barbancho, Beatriz
    Hernandez, Liss
    Vera-Munoz, Cecilia
    Seara, German
    Torrego, Macarena
    Gonzalez, Henar
    Wastesson, Jonas
    Fastbom, Johan
    Mayol, Julio
    Johnell, Kristina
    Gomez-Gascon, Tomas
    Arredondo, Maria Teresa
    HEALTHCARE TECHNOLOGY LETTERS, 2023, 10 (03) : 62 - 72
  • [7] Characterization of the selection of medicines for the Brazilian primary health care
    de Oliveira Karnikowski, Margo Gomes
    Galato, Dayani
    Milward de Azevedo Meiners, Micheline Marie
    da Silva, Emilia Vitoria
    Gerlack, Leticia Farias
    Goncalves Bos, Angelo Jose
    Leite, Silvana Nair
    Alvares, Juliana
    Guibu, Ione Aquemi
    Soeiro, Orlando Mario
    Costa, Karen Sarmento
    Costa, Edina Alves
    Guerra Junior, Augusto Afonso
    Acurcio, Francisco de Assis
    REVISTA DE SAUDE PUBLICA, 2017, 51 : 1s - 9s
  • [8] Role of Primary Health Care in Ensuring Access to Medicines
    Sambala, Evanson Z.
    Sapsed, Susan
    Mkandawire, Mercy L.
    CROATIAN MEDICAL JOURNAL, 2010, 51 (03) : 181 - 190
  • [9] Availability of essential medicines: A primary health care perspective
    Dixit, Rohit
    Vinay, M.
    Jayasree, T.
    Ubedulla, Shaikh
    Manohar, V. S.
    Chandrasekhar, N.
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (05): : 599 - 600
  • [10] Primary care pharmacists as a support for general practitioners in the follow-up of polymedicated patients
    Basco, Aida
    Mar Cervera, Maria
    Modamio, Pilar
    Planellas, Montserrat
    Marino, Eduardo L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 309 - 309